Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Cardiology
Trial Title   XIENCEV Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study (Protocol 06-374)
Description of Research   The purpose of this study is to evaluate the continued safety and effectiveness of the XIENCEV Everolimus Eluting Coronary Stent System (the XIENCE V EECSS) in a group of patients.
Study Number   HSR-08-0963
Principal Investigator   James Bengtson, MD
Phone   (734) 712-8000
A Member of Trinity Health
© 2014 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456